lulizumab pegol (BMS-931699)
Showing 1 - 25 of 945
Kidney Transplantation, Renal Transplant Recipients Trial in Atlanta (Lulizumab, Tacrolimus, Thymoglobulin®)
Not yet recruiting
- Kidney Transplantation
- Renal Transplant Recipients
- Lulizumab
- +5 more
-
Atlanta, GeorgiaEmory University Hospital
Sep 22, 2021
Lupus Trial in Worldwide (BMS-931699, Placebo matching BMS-931699)
Damoctocog Alfa Pegol, How it is Used in Every Day Practice, and
Not yet recruiting
- Hemophilia A
- No intervention
-
Sacramento, California
- +2 more
Jan 10, 2023
Assess How Well Certolizumab Pegol Works in Moderate to Severe
Completed
- Plaque Psoriasis
- Certolizumab pegol
-
Brussels, Belgium
- +78 more
Jan 20, 2023
Geographic Atrophy, Macular Degeneration Trial in Dallas (Avacincaptad pegol 2 mg intravitreal injection)
Not yet recruiting
- Geographic Atrophy
- Macular Degeneration
- Avacincaptad pegol 2 mg intravitreal injection
-
Dallas, TexasRetina Foundation of the Southwest
Sep 7, 2022
Calcium Citrate Absorption, Calcium Carbonate Absorption Trial in Alexandria (The absorption effect between calcium citrate and
Not yet recruiting
- Calcium Citrate Absorption
- Calcium Carbonate Absorption
- The absorption effect between calcium citrate and calcium carbonate
-
Alexandria, EgyptThe surgical department of Medical Research Institute Hospital,
Sep 15, 2023
Burning Mouth Syndrome Trial (drug, other, dietary supplement, radiation)
Not yet recruiting
- Burning Mouth Syndrome
- topical placebo tablet
- +5 more
- (no location specified)
Sep 10, 2023
Systemic Lupus Erythematosus Trial in Worldwide (Dapirolizumab pegol)
Enrolling by invitation
- Systemic Lupus Erythematosus
- Dapirolizumab pegol
-
Tucson, Arizona
- +36 more
Aug 11, 2022
Acute Lymphoblastic Leukemia Trial in Tampa (Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy), Calaspargase
Recruiting
- Acute Lymphoblastic Leukemia
- Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy)
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Oct 12, 2022
Polyarticular-course Juvenile Idiopathic Arthritis (JIA) Trial in Worldwide (Certolizumab Pegol (CZP))
Active, not recruiting
- Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
- Certolizumab Pegol (CZP)
-
Little Rock, Arkansas
- +35 more
Dec 1, 2022
Learn More About Physical Activity Level of Patients Suffering
Recruiting
- Hemophilia A
- Damoctocog alfa pegol (Jivi, BAY94-9027)
-
Orange, California
- +20 more
Dec 19, 2022
Pulmonary Fibrosis Trial in Worldwide (BMS-986278 Placebo, BMS-986278)
Active, not recruiting
- Pulmonary Fibrosis
- BMS-986278 Placebo
- BMS-986278
-
Birmingham, Alabama
- +118 more
Dec 3, 2022
Sjögren's Syndrome Trial in Worldwide (BMS-931699, BMS-986142, Placebo)
Acute Lymphoblastic Leukemia Trial in United States (Calaspargase pegol (S95015))
Recruiting
- Acute Lymphoblastic Leukemia
- Calaspargase pegol (S95015)
-
Scottsdale, Arizona
- +14 more
Dec 13, 2022
Rheumatoid Arthritis Trial in United States (Certolizumab pegol)
Completed
- Rheumatoid Arthritis
- Certolizumab pegol
-
Covina, California
- +8 more
Jul 26, 2022
Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With
Recruiting
- Hemophilia A
- Damoctocog alfa pegol (Jivi, Bay94-9027)
-
Mobile, Alabama
- +36 more
Jan 13, 2023
Burning Mouth Syndrome Trial in Catania (Diazepam 1% oral gel, Placebo)
Recruiting
- Burning Mouth Syndrome
- Diazepam 1% oral gel
- Placebo
-
Catania, ItalyAOU Policlinico G. Rodolico
May 23, 2023
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in
Not yet recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +6 more
- Biopsy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Apr 26, 2022
Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Relapsed and/or Refractory Multiple Myeloma
- BMS-986453
- +2 more
-
Köln, GermanyLocal Institution - 0017
Dec 4, 2023